Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 18, 1997

View Archived Issues

Growth hormone antagonist enters phase II

Alpha1-adrenoceptor antagonists improve symptoms of BPO, BPH in clinical studies

GEM-92 enters clinical trials for AIDS

KMD-3213: a newer alpha1-adrenoceptor antagonist for BPH

KRN-4884 active in several preclinical models of hypertension

Separation of antiobesity and antidiabetic effects of beta3-adrenoceptor agonist established in rats

Anticonvulsant profile of two new GABA uptake inhibitors

Role of osteoprotegerin in skeletal metabolism elucidated

New anthraquinone interacting with telomeric G-quadruplex DNA

3-D database search at Schering-Plough leads to potent, selective FPT inhibitors

Dual ACE/NEP inhibitors described by Zambon

Fujisawa discloses new PDE IV/TNF inhibitors

Known antidiabetic agent modulates glucocorticoid response in osteoclasts

Retinoid-like compounds from Allergan

FDA panel recommends approval of Anesta's Actiq for cancer pain

Efavirenz/indinavir combination shows efficacy in phase II

Novel osteoclast resorption inhibitor isolated by Swiss investigators

New raloxifene analogue from Lilly is a potent SERM

Potent and selective N-type calcium channel blockers for stroke

Oxford GlycoSciences' OGT-719 enters clinical testing

TheraTech and Astra sign agreement for Androderm distribution

Dopamine D1/D2 coactivation maximizes metabolic responses in obese mice

October launch for Zanaflex in U.K.

U.S. introduction for FemPatch

Asta Medica and Wyeth-Ayerst agreement for epilepsy drug

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...